SENIOR CONVERTIBLE DEBENTURE DUE SEPTEMBER July 16, 2020Inspyr Therapeutics, Inc. • March 6th, 2020 • Pharmaceutical preparations • New York
THIS SENIOR CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Senior Convertible Debentures of Inspyr Therapeutics, Inc., a Delaware corporation (the “Company”), having its principal place of business at 31200 Via Colinas, Suite 200, Westlake Village, California 91362, designated as its Senior Convertible Debenture due July 16, 2020 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
